Medicare Enrolled
Dr. Victor Jose Meceda, M.D.
General Acute Care Hospital · San Jose, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Meceda from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Meceda?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Meceda
Dr. Victor Jose Meceda is a general acute care hospital specialist in San Jose, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Meceda performed 1,442 Medicare services across 628 unique beneficiaries.
Between the years covered by Open Payments, Dr. Meceda received a total of $8,220 from 43 pharmaceutical and/or device companies across 401 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in general acute care hospital. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Meceda is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 12% volume in CA
$8,220 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,442
Medicare services
Top 12% in CA for general acute care hospital
628
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~90 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
660 | $95 | $132 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
265 | $87 | $225 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
85 | $151 | $274 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
66 | $59 | $80 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
52 | $139 | $182 |
| Nursing facility discharge management, more than 30 minutes This service involves care coordination and management activities performed by a healthcare professional to prepare a patient for discharge from a nursing facility. It requires more than 30 minutes of time spent on these activities. |
46 | $106 | $135 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
41 | $59 | $189 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
39 | $37 | $60 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
34 | $72 | $100 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
29 | $8 | $14 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
28 | $10 | $30 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
25 | $10 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
24 | $8 | $18 |
| New patient office visit, complex (60-74 min) | 21 | $154 | $325 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
16 | $13 | $30 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
11 | $18 | $120 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,220
Total received (2018-2024)
Avg $1,174/year across 7 years
Top 11% in CA for general acute care hospital
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
401
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,220 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,303
2023
$1,790
2022
$881
2021
$624
2020
$433
2019
$966
2018
$1,223
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
IBSA Pharma Inc.
$337
AstraZeneca Pharmaceuticals LP
$319
GlaxoSmithKline, LLC.
$284
Novo Nordisk Inc
$200
Novartis Pharmaceuticals Corporation
$190
Esperion Therapeutics, Inc.
$145
Boehringer Ingelheim Pharmaceuticals, Inc.
$132
Abbott Laboratories
$114
Amgen Inc.
$110
Lilly USA, LLC
$90
Bayer Healthcare Pharmaceuticals Inc.
$78
Xeris Pharmaceuticals, Inc.
$72
PFIZER INC.
$68
Eisai Inc.
$46
SANOFI-AVENTIS U.S. LLC
$36
Kiniksa Pharmaceuticals International, plc
$29
Dexcom, Inc.
$28
Agios Pharmaceuticals, Inc.
$25
Top 3 companies account for 40.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,176
AstraZeneca Pharmaceuticals LP
$795
Boehringer Ingelheim Pharmaceuticals, Inc.
$625
Janssen Pharmaceuticals, Inc
$589
Novartis Pharmaceuticals Corporation
$496
Amgen Inc.
$463
IBSA Pharma Inc.
$429
Lilly USA, LLC
$412
PFIZER INC.
$356
GlaxoSmithKline, LLC.
$339
Abbott Laboratories
$287
Bayer Healthcare Pharmaceuticals Inc.
$225
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$212
SANOFI-AVENTIS U.S. LLC
$200
Esperion Therapeutics, Inc.
$186
E.R. Squibb & Sons, L.L.C.
$148
AbbVie, Inc.
$139
Dexcom, Inc.
$123
Merck Sharp & Dohme Corporation
$103
AbbVie Inc.
$88
Amarin Pharma Inc.
$76
Medtronic Vascular, Inc.
$73
Xeris Pharmaceuticals, Inc.
$72
NESTLE HEALTHCARE NUTRITION INC.
$62
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$59
Bayer HealthCare Pharmaceuticals Inc.
$57
Eisai Inc.
$46
ABBVIE INC.
$39
Paratek Pharmaceuticals, Inc.
$37
Gilead Sciences, Inc.
$36
Genentech USA, Inc.
$35
Teva Pharmaceuticals USA, Inc.
$29
Kiniksa Pharmaceuticals International, plc
$29
Agios Pharmaceuticals, Inc.
$25
Synergy Pharmaceuticals Inc
$24
Merck Sharp & Dohme LLC
$20
Intercept Pharmaceuticals, Inc.
$20
Kiniksa Pharmaceuticals, Ltd.
$19
Rigel Pharmaceuticals, Inc.
$17
Ultragenyx Pharmaceutical Inc.
$14
Otsuka America Pharmaceutical, Inc.
$13
Arbor Pharmaceuticals, Inc.
$12
Allergan Inc.
$11
Top 3 companies account for 31.6% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · AJOVY · AREXVY · AVEIR · Arcalyst · BASAGLAR · BELSOMRA · BREZTRI · BRILINTA · BYDUREON · BYSTOLIC · CHANTIX · Crysvita · DALIRESP · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbyclor · FARXIGA · FASENRA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre Pro · GALLANT · GVOKE HYPOPEN · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LICART · Leqembi · Licart · LifeVest · MAVYRET · MOUNJARO · Mavyret · NEXLETOL · NEXLIZET · NUEDEXTA · NUZYRA · OCALIVA · Otezla · Ozempic · PRADAXA · PYRUKYND · Prolia · RYBELSUS · Repatha · Reveal LINQ · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TZIELD · Tavalisse · Tirosint · Trulance · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · Xofluza · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
General acute care hospitals within 10 mi
24
Per 100K population
1.3
County median income
$159,674
Nearest hospital
REGIONAL MEDICAL CENTER OF SAN JOSE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Meceda is a clinical cardiology specialist, with above-average Medicare volume (top 12% in CA), with low-engagement industry engagement in the top 11% of CA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Meceda experienced with nursing facility visit, moderate complexity?
Based on Medicare claims data, Dr. Meceda performed 660 nursing facility visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Meceda receive payments from pharmaceutical companies?
Yes. Dr. Meceda received a total of $8,220 from 43 companies across 401 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Meceda's costs compare to other general acute care hospitals in San Jose?
Dr. Meceda's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Meceda) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
General Acute Care Hospitals in San Jose
Browse general acute care hospitals in San Jose ranked by procedure volume and transparency data.
Highest volume
Top General Acute Care Hospitals in CA
General acute care hospitals ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to General Acute Care Hospitals in CA
Which CA general acute care hospitals receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology